Logo image of TKA.DE

THYSSENKRUPP AG (TKA.DE) Stock Fundamental Analysis

FRA:TKA - Deutsche Boerse Ag - DE0007500001 - Common Stock - Currency: EUR

9.288  -0.07 (-0.77%)

Fundamental Rating

3

Overall TKA gets a fundamental rating of 3 out of 10. We evaluated TKA against 38 industry peers in the Metals & Mining industry. TKA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TKA has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year TKA has reported negative net income.
TKA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: TKA reported negative net income in multiple years.
TKA had a positive operating cash flow in 4 of the past 5 years.
TKA.DE Yearly Net Income VS EBIT VS OCF VS FCFTKA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B

1.2 Ratios

TKA's Return On Assets of -4.12% is on the low side compared to the rest of the industry. TKA is outperformed by 73.68% of its industry peers.
TKA has a worse Return On Equity (-11.40%) than 81.58% of its industry peers.
Industry RankSector Rank
ROA -4.12%
ROE -11.4%
ROIC N/A
ROA(3y)-2.82%
ROA(5y)3.5%
ROE(3y)-8.41%
ROE(5y)14.28%
ROIC(3y)N/A
ROIC(5y)N/A
TKA.DE Yearly ROA, ROE, ROICTKA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

TKA has a worse Gross Margin (9.83%) than 76.32% of its industry peers.
In the last couple of years the Gross Margin of TKA has declined.
The Profit Margin and Operating Margin are not available for TKA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.26%
GM growth 5Y-3.17%
TKA.DE Yearly Profit, Operating, Gross MarginsTKA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

5

2. Health

2.1 Basic Checks

TKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
TKA has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for TKA remains at a similar level compared to 5 years ago.
The debt/assets ratio for TKA has been reduced compared to a year ago.
TKA.DE Yearly Shares OutstandingTKA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
TKA.DE Yearly Total Debt VS Total AssetsTKA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

TKA has an Altman-Z score of 1.74. This is a bad value and indicates that TKA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.74, TKA is doing worse than 60.53% of the companies in the same industry.
TKA has a debt to FCF ratio of 4.66. This is a neutral value as TKA would need 4.66 years to pay back of all of its debts.
TKA has a Debt to FCF ratio of 4.66. This is in the better half of the industry: TKA outperforms 73.68% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that TKA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.06, TKA belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 4.66
Altman-Z 1.74
ROIC/WACCN/A
WACC7.27%
TKA.DE Yearly LT Debt VS Equity VS FCFTKA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

TKA has a Current Ratio of 1.85. This is a normal value and indicates that TKA is financially healthy and should not expect problems in meeting its short term obligations.
TKA has a Current ratio of 1.85. This is in the better half of the industry: TKA outperforms 65.79% of its industry peers.
TKA has a Quick Ratio of 1.16. This is a normal value and indicates that TKA is financially healthy and should not expect problems in meeting its short term obligations.
TKA has a Quick ratio of 1.16. This is in the better half of the industry: TKA outperforms 65.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.16
TKA.DE Yearly Current Assets VS Current LiabilitesTKA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

3

3. Growth

3.1 Past

The earnings per share for TKA have decreased strongly by -5705.01% in the last year.
The Revenue has decreased by -5.47% in the past year.
TKA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.58% yearly.
EPS 1Y (TTM)-5705.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%185.71%
Revenue 1Y (TTM)-5.47%
Revenue growth 3Y1%
Revenue growth 5Y0.58%
Sales Q2Q%-4.28%

3.2 Future

Based on estimates for the next years, TKA will show a very strong growth in Earnings Per Share. The EPS will grow by 37.71% on average per year.
The Revenue is expected to grow by 1.91% on average over the next years.
EPS Next Y138.66%
EPS Next 2Y57.36%
EPS Next 3Y37.71%
EPS Next 5YN/A
Revenue Next Year-0.97%
Revenue Next 2Y1.16%
Revenue Next 3Y1.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TKA.DE Yearly Revenue VS EstimatesTKA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B 40B
TKA.DE Yearly EPS VS EstimatesTKA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

6

4. Valuation

4.1 Price/Earnings Ratio

TKA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 10.77 indicates a reasonable valuation of TKA.
Based on the Price/Forward Earnings ratio, TKA is valued a bit cheaper than 68.42% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of TKA to the average of the S&P500 Index (21.91), we can say TKA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.77
TKA.DE Price Earnings VS Forward Price EarningsTKA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TKA is valued cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TKA is valued a bit cheaper than 73.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.9
EV/EBITDA 1.66
TKA.DE Per share dataTKA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

TKA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TKA's earnings are expected to grow with 37.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.36%
EPS Next 3Y37.71%

0

5. Dividend

5.1 Amount

No dividends for TKA!.
Industry RankSector Rank
Dividend Yield N/A

THYSSENKRUPP AG

FRA:TKA (3/28/2025, 1:26:44 PM)

9.288

-0.07 (-0.77%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-15 2025-05-15
Inst Owners29.93%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.78B
Analysts72
Price Target6.44 (-30.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.15
Dividend Growth(5Y)0.88%
DP-7.48%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-317.11%
Min EPS beat(2)-573.83%
Max EPS beat(2)-60.4%
EPS beat(4)0
Avg EPS beat(4)-199.2%
Min EPS beat(4)-573.83%
Max EPS beat(4)-27.99%
EPS beat(8)1
Avg EPS beat(8)-157.83%
EPS beat(12)3
Avg EPS beat(12)-105.2%
EPS beat(16)5
Avg EPS beat(16)-61.82%
Revenue beat(2)0
Avg Revenue beat(2)-1.78%
Min Revenue beat(2)-2.78%
Max Revenue beat(2)-0.78%
Revenue beat(4)0
Avg Revenue beat(4)-4.09%
Min Revenue beat(4)-8.89%
Max Revenue beat(4)-0.78%
Revenue beat(8)1
Avg Revenue beat(8)-0.98%
Revenue beat(12)5
Avg Revenue beat(12)1.23%
Revenue beat(16)8
Avg Revenue beat(16)1.21%
PT rev (1m)17.84%
PT rev (3m)33.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-1.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.77
P/S 0.17
P/FCF 17.9
P/OCF 2.78
P/B 0.53
P/tB 0.63
EV/EBITDA 1.66
EPS(TTM)-1.68
EYN/A
EPS(NY)0.86
Fwd EY9.29%
FCF(TTM)0.52
FCFY5.59%
OCF(TTM)3.35
OCFY36.03%
SpS55.73
BVpS17.52
TBVpS14.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.12%
ROE -11.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.83%
FCFM 0.93%
ROA(3y)-2.82%
ROA(5y)3.5%
ROE(3y)-8.41%
ROE(5y)14.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.26%
GM growth 5Y-3.17%
F-Score7
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 4.66
Debt/EBITDA 0.65
Cap/Depr 97.08%
Cap/Sales 5.07%
Interest Coverage N/A
Cash Conversion 203.82%
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.16
Altman-Z 1.74
F-Score7
WACC7.27%
ROIC/WACCN/A
Cap/Depr(3y)76.43%
Cap/Depr(5y)79.46%
Cap/Sales(3y)4.13%
Cap/Sales(5y)4.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5705.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%185.71%
EPS Next Y138.66%
EPS Next 2Y57.36%
EPS Next 3Y37.71%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.47%
Revenue growth 3Y1%
Revenue growth 5Y0.58%
Sales Q2Q%-4.28%
Revenue Next Year-0.97%
Revenue Next 2Y1.16%
Revenue Next 3Y1.91%
Revenue Next 5YN/A
EBIT growth 1Y57.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year207.67%
EBIT Next 3Y54.1%
EBIT Next 5YN/A
FCF growth 1Y265.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.05%
OCF growth 3Y145%
OCF growth 5Y79.8%